CGP 35949, an LTD4 antagonist with phospholipase inhibitory activity: a new approach to the treatment of asthma.
D001249:Asthma / Q000188:drug therapy; D001393:Azoles / Q000494:pharmacology*; D002867:Chromones / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D010741:Phospholipases A / Q000037:antagonists & inhibitors; D013189:SRS-A / Q000037:antagonists & inhibitors*; D013329:Structure-Activity Relationship; D013777:Tetrazoles / Q000494:pharmacology*
D001393:Azoles; D002867:Chromones; D013189:SRS-A; D013777:Tetrazoles; C052972:CGP 35949; C006312:FPL 55712; D010741:Phospholipases A